Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.2%

2 terminated/withdrawn out of 91 trials

Success Rate

97.3%

+10.8% vs industry average

Late-Stage Pipeline

45%

41 trials in Phase 3/4

Results Transparency

4%

3 of 73 completed trials have results

Key Signals

7 recruiting3 with results

Enrollment Performance

Analytics

Phase 1
29(36.7%)
Phase 4
22(27.8%)
Phase 3
19(24.1%)
Phase 2
8(10.1%)
N/A
1(1.3%)
79Total
Phase 1(29)
Phase 4(22)
Phase 3(19)
Phase 2(8)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (91)

Showing 20 of 91 trials
NCT05815901Phase 3Completed

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

Role: lead

NCT07378098Phase 3Recruiting

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

Role: lead

NCT07036458Phase 1Completed

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Role: lead

NCT07374406Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Role: lead

NCT07514780Phase 1Recruiting

To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

Role: lead

NCT06665425Phase 1Completed

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

Role: lead

NCT06435442Phase 1Completed

PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers

Role: lead

NCT07523971Recruiting

Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study

Role: lead

NCT07488611Phase 3Recruiting

PROGAIN Trial in Gastric Cancer Surgery

Role: collaborator

NCT07445542Completed

Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia

Role: lead

NCT07442630Phase 4Active Not Recruiting

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

Role: lead

NCT07442006Phase 4Recruiting

Glycemic Variability of Combination Therapies in T2DM

Role: lead

NCT07382778Completed

Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

Role: lead

NCT03055286Phase 1Terminated

Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Role: lead

NCT05814406Phase 3Completed

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM

Role: lead

NCT06643130Phase 3Recruiting

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Role: lead

NCT06754943Phase 1Completed

To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105

Role: lead

NCT05814393Phase 3Completed

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT01764178Phase 1Completed

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

Role: lead

NCT06955104Phase 3Completed

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

Role: lead